Here is a complete viva Q&A for an Ascites clinical case, sourced from Harrison's Principles of Internal Medicine 22E and Frameworks for Internal Medicine.
Ascites - Case Viva Questions & Answers
Q1. Define Ascites.
A: Ascites is the abnormal accumulation of fluid within the peritoneal cavity. The most common cause is portal hypertension related to cirrhosis, but malignant, infectious, and cardiac causes must also be considered.
- Harrison's Principles of Internal Medicine 22E, p.2758
Q2. What are the causes of ascites? How do you classify them?
A: Best classified using the SAAG (Serum-Ascites Albumin Gradient):
| SAAG ≥ 1.1 g/dL (Portal Hypertension) | SAAG < 1.1 g/dL (Non-Portal HTN) |
|---|
| Cirrhosis (most common) | Tuberculous peritonitis |
| Congestive cardiac failure | Peritoneal carcinomatosis |
| Budd-Chiari syndrome | Pancreatic ascites |
| Sinusoidal obstruction (veno-occlusive disease) | Nephrotic syndrome |
| Massive liver metastases | Bowel obstruction/infarction |
Q3. What is the pathogenesis of ascites in cirrhosis?
A: (Peripheral vasodilation / Underfill theory)
Key steps:
- Cirrhosis → increased intrahepatic resistance → portal hypertension
- Portal hypertension → splanchnic arterial vasodilation (mediated by nitric oxide)
- Vasodilation → arterial underfilling (perceived hypovolemia)
- Compensatory activation of RAAS + SNS → aldosterone excess + sympathetic activation → sodium and water retention
- Increased portal venous inflow + increased splanchnic lymph production
- Hypoalbuminemia → reduced plasma oncotic pressure → fluid leaks into peritoneal cavity
- Net result: fluid accumulates in the peritoneal cavity faster than it can be reabsorbed
Q4. What are the clinical features of ascites?
A:
- Symptoms: Increase in abdominal girth, abdominal fullness/discomfort, dyspnea (if massive), fatigue, early satiety. At least 1-2 L of fluid must accumulate before the patient notices.
- Signs on examination:
- Abdominal distension
- Bulging flanks
- Shifting dullness - most sensitive bedside test (moves with position)
- Fluid wave / fluid thrill - requires large amounts of fluid; a helper must press in the midline to block fat-wave transmission
- Everted umbilicus (umbilical hernia in massive ascites)
- Pedal edema
Q5. How do you diagnose ascites? What is the first investigation you would do?
A:
- Clinical examination (shifting dullness, fluid wave)
- Ultrasound abdomen - can detect as little as 100 mL; most sensitive imaging
- Diagnostic paracentesis is mandatory when ascites is first detected - to characterize the fluid and rule out SBP
Routine fluid tests on paracentesis:
- SAAG calculation (serum albumin - ascitic albumin)
- Cell count with differential
- Total protein
- Glucose
- LDH
- Gram stain + culture (inoculate blood culture bottles at bedside)
- Cytology (if malignancy suspected - send ≥50 mL)
- Amylase (if pancreatic ascites suspected)
Q6. What is the SAAG? How is it calculated and interpreted?
A:
SAAG = Serum albumin - Ascitic fluid albumin (both in g/dL)
| Value | Interpretation | Examples |
|---|
| ≥ 1.1 g/dL | Portal hypertension | Cirrhosis, cardiac ascites, Budd-Chiari, sinusoidal obstruction |
| < 1.1 g/dL | Non-portal hypertension | TB peritonitis, peritoneal carcinomatosis, pancreatic ascites, nephrotic syndrome |
Key points:
- SAAG reflects the pressure in hepatic sinusoids and correlates with the hepatic venous pressure gradient (HVPG)
- SAAG does not change with diuresis (unlike older transudate/exudate classification)
- SAAG is superior to the exudate-transudate concept
Further differentiation in high-SAAG ascites using ascitic protein:
| Ascitic protein | Meaning |
|---|
| ≥ 2.5 g/dL | Sinusoids are normal - cardiac ascites, early Budd-Chiari, sinusoidal obstruction |
| < 2.5 g/dL | Sinusoids scarred/damaged - cirrhosis, late Budd-Chiari, massive liver metastases |
Q7. What is the gross appearance of ascitic fluid and its significance?
A:
| Appearance | Likely Cause |
|---|
| Clear, pale straw-colored | Normal/uncomplicated ascites |
| Hazy, cloudy, turbid | Infection (SBP) or tumor cells |
| Milky/chylous | Triglyceride >200 mg/dL (often >1000 mg/dL) - lymphatic disruption (trauma, cirrhosis, TB, tumor) |
| Frank blood (hemorrhagic) | Malignancy, trauma, coagulopathy |
| Dark brown | High bilirubin; if ascitic bilirubin > serum bilirubin → ruptured gallbladder or perforated duodenal ulcer |
| Black | Pancreatic necrosis or metastatic melanoma |
Q8. What does the cell count of ascitic fluid tell you?
A:
- Neutrophil (PMN) count ≥ 250 cells/mm³ → Spontaneous Bacterial Peritonitis (SBP) - treat empirically
- Lymphocytosis in ascitic fluid → Tuberculosis peritonitis or malignancy
- WBC >500, PMN >250 with multiple organisms on culture → Secondary bacterial peritonitis (perforated viscus)
Q9. How do you differentiate SBP from secondary bacterial peritonitis?
A:
| Feature | SBP | Secondary Bacterial Peritonitis |
|---|
| PMN count | ≥ 250/mm³ | Typically much higher |
| Organisms | Single organism | Multiple organisms |
| Glucose | Normal | < 50 mg/dL |
| LDH | < serum LDH | > serum LDH |
| Protein | Usually low | Usually elevated |
| Surgical abdomen signs | Absent | Present |
| Management | IV antibiotics (no surgery) | Surgical emergency |
Q10. What is the management of ascites?
A:
Step 1 - Mild to moderate ascites:
- Dietary sodium restriction: 2 g/day (avoid canned/processed foods)
- Diuretics:
- Spironolactone 100 mg/day (first-line - blocks aldosterone)
- Add Furosemide 40 mg/day (especially if peripheral edema)
- Ratio maintained at 100:40 (spironolactone:furosemide) to maintain normokalemia
- Max doses: Spironolactone 400 mg/day, Furosemide 160 mg/day
Monitoring diuresis:
- Target weight loss: 0.5 kg/day (without edema); 1 kg/day (with edema)
Step 2 - Refractory ascites (failure of max-dose diuretics + sodium restriction):
- Large-Volume Paracentesis (LVP): For ≥5 L removal, give IV 25% albumin 6-8 g per liter removed to prevent circulatory dysfunction / post-paracentesis circulatory dysfunction (PPCD)
- TIPS (Transjugular Intrahepatic Portosystemic Shunt): Effective but does not improve survival; increases risk of hepatic encephalopathy
- Liver transplantation: Definitive treatment; should be considered since <50% of patients with cirrhotic ascites survive 2 years
Q11. What is the prognosis of cirrhotic ascites?
A: Poor - studies show that less than 50% of patients with cirrhosis and ascites survive 2 years after onset. This is a marker for end-stage liver disease, and liver transplant evaluation should be initiated promptly.
Q12. What drugs should be avoided in cirrhotic ascites?
A:
- NSAIDs - cause renal vasoconstriction, precipitate AKI/hepatorenal syndrome
- Aminoglycosides - nephrotoxic
- ACE inhibitors / ARBs - use with great caution; can cause hypotension and worsen renal function
- Beta-blockers - need reassessment; in patients with SBP or refractory ascites, beta-blockers may worsen survival and circulatory dysfunction (viva hot topic!)
Q13. What is Spontaneous Bacterial Peritonitis (SBP)?
A:
- Spontaneous infection of ascitic fluid without an identifiable intraabdominal source
- Occurs in up to 30% of hospitalized cirrhotic patients with ascites
- In-hospital mortality: ~25%
- Mechanism: bacterial translocation - gut flora traverse intestinal wall → mesenteric lymph nodes → bacteremia → seeding of ascites
- Most common organisms: E. coli, Klebsiella, Streptococcus pneumoniae (gram-negatives predominate)
- Treatment: Cefotaxime IV (3rd-generation cephalosporin); albumin infusion (1.5 g/kg at diagnosis, 1 g/kg on day 3) reduces risk of hepatorenal syndrome and mortality
- Prophylaxis: Norfloxacin or Trimethoprim-sulfamethoxazole for secondary prevention
Q14. What is hepatic hydrothorax?
A: Passage of ascitic fluid into the thoracic cavity through diaphragmatic defects (rents), more common on the right side. Results in a pleural effusion in a cirrhotic patient without primary cardiac or pulmonary disease. Management mirrors ascites management; TIPS can be considered in refractory cases.
Summary Table - Ascitic Fluid Interpretation
| Test | Normal | SBP | Malignancy | TB | Cardiac | Cirrhosis |
|---|
| Color | Straw | Cloudy | Bloody/cloudy | Yellow | Straw | Straw |
| SAAG | - | ≥1.1 | <1.1 | <1.1 | ≥1.1, protein >2.5 | ≥1.1, protein <2.5 |
| PMN | <250 | ≥250 | Variable | Low | Low | Low |
| Protein | - | Low | High | High | >2.5 | <2.5 |
| Cytology | Neg | Neg | Positive | Neg | Neg | Neg |
| Culture | Neg | Single organism | Neg | AFB | Neg | Neg |
Sources: Harrison's Principles of Internal Medicine 22E, p.2758-2759; Frameworks for Internal Medicine, p.165-176; Sleisenger & Fordtran's GI and Liver Disease